Merck & Co., Inc.
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30250% above fair value
$149.52+3.19 (+2.18%)
Close on Oct 30, 2026Market cap $368.89BP/E 119.6Yield 2.19%
Merck Total Vaccines Franchise — Worldwide sales by Year
Total Vaccines Franchise — Worldwide sales ($M) ($M)
Merck Total Vaccines Franchise — Worldwide sales: $10,711M in FY2025, down 20.4% from a year earlier.
Latest, FY2025
10,711
Period ended Dec 31, 2025
Change on a year earlier
-20.4%
13,448 in FY2024
History
9 years
Since FY2017
Sources
6
Documents cited below
Where the FY2025 figure comes from
“Total Vaccines sales were $10,711 million and $13,448 million”
Source: Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗
Reported in Form 8-K Supplemental Table 3 Footnote (Total Vaccines sales).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Total Vaccines Franchise — Worldwide sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 10,711 | -20.4% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2024 | Dec 31, 2024 | 13,448 | -1.5% | Form 8-K (tm264564d1_ex99-1.htm, filed 2026-02-03) ↗ |
| FY2023 | Dec 31, 2023 | 13,654 | +20.9% | Form 8-K (tm255059d1_ex99-1.htm, filed 2025-02-04) ↗ |
| FY2022 | Dec 31, 2022 | 11,297 | +11.5% | Form 8-K (tm244517d1_ex99-1.htm, filed 2024-02-01) ↗ |
| FY2021 | Dec 31, 2021 | 10,132 | +22.7% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2020 | Dec 31, 2020 | 8,258 | -1.3% | Form 8-K (tm222755d1_ex99-1.htm, filed 2022-02-03) ↗ |
| FY2019 | Dec 31, 2019 | 8,368 | +15.2% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2018 | Dec 31, 2018 | 7,262 | +10.9% | Form 8-K (tm206551d1_ex99-1.htm, filed 2020-02-05) ↗ |
| FY2017 | Dec 31, 2017 | 6,547 | – | Form 8-K (a19-3795_1ex99d1.htm, filed 2019-02-01) ↗ |
Cite this data
StockData. (2026). Merck Total Vaccines Franchise — Worldwide sales ($M), annual FY2017–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/rev-total-vaccines
See every metric in the Merck KPI table. Data updated Oct 26, 2026.